Showing results (661-670 of 1,395) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|October 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyFrancis P Worden, Evan Pisick, Michael Rothe, et al.
JCO Precision Oncology|May 28, 2026
Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan-Treated Human Epidermal Growth Factor Receptor 2-Positive Gastric CancerAnsh Kapil, Henrik Failmezger, Yu Fu, et al.
JCO Precision Oncology|December 31, 2019
Parental Perspectives on Whole Exome Sequencing in Pediatric Cancer: A Typology of Perceived UtilityJanet Malek, Melody J Slashinski, Jill O Robinson, et al.
JCO Precision Oncology|May 11, 2026
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0Angela Silvestro, Jonathan Baden, Kevin Billings, et al.
JCO Precision Oncology|May 14, 2026
Increased Selfness in the Tumor Emerges as a Possible Immune Sculpting MechanismNaren Chandran Sakthivel, Anoushka Chinmayi, Nagasuma Chandra
JCO Precision Oncology|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung CancerN Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
JCO Precision Oncology|May 14, 2026
Homozygous Loss of Recombination Repair Genes and Poly ADP-Ribose Polymerase Inhibitor Benefit for Patients With Ovarian CancerElizabeth M Swisher, Gottfried Konecny, Joshua Cohen, et al.
JCO Precision Oncology|May 14, 2026
Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling PlatformsDean C Pavlick, Shruthi Rengarajan, Jessica K Lee, et al.
JCO Precision Oncology|March 9, 2026
Unique Features of a Comprehensive Genomic Profiling Panel: Expanding Treatment Options in a Value-Based Community Oncology NetworkPaul La Porte, Arya Ashok, Nathan W Sweeney, et al.
JCO Precision Oncology|March 5, 2026
Impact of Germline BRCA Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreatic Cancer: An Exploratory AnalysisLingaku Lee, Yuichi Tachibana, Susumu Matsuo, et al.
Pageof 140